NexImmune (7370) Stock Statistics & Valuation Metrics
Total Valuation
NexImmune has a market cap or net worth of EUR 124.00. The enterprise value is EUR 1.37M.
- Market Cap
- EUR 124.00
- Enterprise Value
- EUR 1.37M
Share Statistics
NexImmune has 1,394,671 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,394,671
- Owned by Insiders
- ―
- Owned by Institutions
- 7.71%
Financial Efficiency
NexImmune’s return on equity (ROE) is -9.22 and return on invested capital (ROIC) is -800.38%.
- Return on Equity (ROE)
- -9.22
- Return on Assets (ROA)
- -3.76
- Return on Invested Capital (ROIC)
- -800.38%
- Return on Capital Employed (ROCE)
- -8.32
- Revenue Per Employee
- 0
- Profits Per Employee
- -5.39M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of NexImmune is -0.00. NexImmune’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, NexImmune had revenue of 0 and earned -32.34M in profits. Earnings per share was -30.82.
- Revenue
- 0
- Gross Profit
- -1.02M
- Operating Income
- -29.19M
- Pretax Income
- -32.34M
- Net Income
- -32.34M
- EBITDA
- -28.17M
- Earnings Per Share (EPS)
- -30.82
Cash Flow
In the last 12 months, operating cash flow was -17.61M and capital expenditures -48.67M, giving a free cash flow of -66.28M billion.
- Operating Cash Flow
- -17.61M
- Free Cash Flow
- -66.28M
- Free Cash Flow per Share
- -30.00
Dividends & Yields
NexImmune pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -22646846.04%
- Earnings Yield
- -30819798.22%
Stock Price Statistics
- Beta
- ―
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 3.30
- 200-Day Moving Average
- 3.30
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
NexImmune upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 07, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
NexImmune as a current ratio of 1.06, with Debt / Equity ratio of 1.96%
- Current Ratio
- 1.06
- Quick Ratio
- 1.06
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- 0.11
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, NexImmune has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
NexImmune EV to EBITDA ratio is 0.11, with an EV/FCF ratio of 0.10.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.11
- EV to Free Cash Flow
- 0.10
- EV to Operating Cash Flow
- 0.10
Balance Sheet
NexImmune has EUR 2.42M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 2.42M billion.
- Cash & Marketable Securities
- EUR 2.42M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 2.42M
- Net Cash Per Share
- EUR 1.74
- Tangible Book Value Per Share
- EUR 0.67
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
